1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of brain cancer
5.1.1.2. Rise in the number of cigarette smokers
5.1.1.3. Growth in the number of private diagnostic centers and rising public-private partnerships
5.1.2. Restraints
5.1.2.1. Heavy costs associated with diagnosis and low awareness about the diagnosis
5.1.3. Opportunities
5.1.3.1. Technological advancement in diagnostics devices
5.1.3.2. Development of diagnostic approaches for various cancer mutations
5.1.4. Challenges
5.1.4.1. Rising risk of high radiation exposure and stringent regulatory guidelines
5.2. Cumulative Impact of COVID-19

6. Brain Cancer Diagnostics Market, by Test Type
6.1. Introduction
6.2. Magnetic Resonance Imaging
6.3. Magnetic Resonance Spectroscopy
6.4. PET Scan
6.5. Spinal Tap

7. Brain Cancer Diagnostics Market, by Brain Cancer Type
7.1. Introduction
7.2. Acoustic Neuroma
7.3. Astrocytomas
7.4. Chordomas
7.5. Ependymomas

8. Americas Brain Cancer Diagnostics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Brain Cancer Diagnostics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Brain Cancer Diagnostics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Associated Regional and University Pathologists, Inc.
12.3. Becton, Dickinson and Company,
12.4. Bristol Myer Squibb Co
12.5. ClinSpec Diagnostics Limited
12.6. F. Hoffmann-La Roche AG
12.7. Fujifilm Corporation
12.8. GE Healthcare
12.9. Hitachi, Ltd.
12.10. Hologic, Inc.
12.11. Illumina, Inc.
12.12. Invitae Corporation
12.13. Johns Hopkins University
12.14. Koninklijke Philips N.V.
12.15. Moffitt Cancer Center
12.16. NantOmics
12.17. NeoGenomics Laboratories, Inc.
12.18. Rory David Deutsch Foundation
12.19. Siemens Healthineers AG
12.20. Thermo Fisher Scientific, Inc.
12.21. Toshiba Corporation

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2027
FIGURE 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE SPECTROSCOPY, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET SCAN, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET SCAN, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SPINAL TAP, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SPINAL TAP, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BRAIN CANCER TYPE, 2020 VS 2027 (%)
FIGURE 15. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BRAIN CANCER TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BRAIN CANCER TYPE, 2027
FIGURE 17. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ACOUSTIC NEUROMA, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ACOUSTIC NEUROMA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMAS, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMAS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CHORDOMAS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CHORDOMAS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EPENDYMOMAS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EPENDYMOMAS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 25. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. AUSTRALIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. INDIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. INDONESIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. JAPAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. MALAYSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. PHILIPPINES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. SINGAPORE BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. SOUTH KOREA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. TAIWAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. THAILAND BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. ITALY BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. NETHERLANDS BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. QATAR BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. SAUDI ARABIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. SOUTH AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SPAIN BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. UNITED ARAB EMIRATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 56. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BRAIN CANCER DIAGNOSTICS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY PET SCAN, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY SPINAL TAP, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY BRAIN CANCER TYPE, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ACOUSTIC NEUROMA, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY ASTROCYTOMAS, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY CHORDOMAS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET SIZE, BY EPENDYMOMAS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. AMERICAS BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 14. ARGENTINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 15. BRAZIL BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. CANADA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. MEXICO BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. AUSTRALIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. CHINA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. INDIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. INDONESIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. JAPAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. MALAYSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. PHILIPPINES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. SINGAPORE BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. SOUTH KOREA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. TAIWAN BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. THAILAND BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. FRANCE BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. GERMANY BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. ITALY BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. NETHERLANDS BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. QATAR BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. RUSSIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. SAUDI ARABIA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. SOUTH AFRICA BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. SPAIN BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. UNITED ARAB EMIRATES BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. UNITED KINGDOM BRAIN CANCER DIAGNOSTICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: SCORES
TABLE 44. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 45. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 46. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: RANKING
TABLE 47. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 48. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 49. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 50. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 51. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 52. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 53. GLOBAL BRAIN CANCER DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Associated Regional and University Pathologists, Inc.
Becton, Dickinson and Company,
Bristol Myer Squibb Co
ClinSpec Diagnostics Limited
F. Hoffmann-La Roche AG
Fujifilm Corporation
GE Healthcare
Hitachi, Ltd.
Hologic, Inc.
Illumina, Inc.
Invitae Corporation
Johns Hopkins University
Koninklijke Philips N.V.
Moffitt Cancer Center
NantOmics
NeoGenomics Laboratories, Inc.
Rory David Deutsch Foundation
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Toshiba Corporation